SCHEMBL9201196

SCHEMBL9201196

OC1CCn2ccnc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19220304 1.00
SCHEMBL21945204 1.00
SCHEMBL23704527 0.88 LRRK2 (0.31)
SCHEMBL26780073 0.78 ADRA1A (0.30)
SCHEMBL25515636 0.78 ADRA1A (0.30)
SCHEMBL15807962 0.75
SCHEMBL30892164 0.75
SCHEMBL29215649 0.75
SCHEMBL24146813 0.75
SCHEMBL17145125 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120058708-A Alkynyl alcohol derivative and medical application thereof 中国药科大学 2025-05-30 CN claimed
US-12617789-B2 Small molecular inhibitors of NF-κb inducing kinase JANSSEN PHARMACEUTICA NV (BE) 2026-05-05 US disclosed
US-20250207171-A1 KETOREDUCTASE POLYPEPTIDES AND POLYNUCLEOTIDES CODEXIS INC (RE) 2025-06-26 US disclosed
CN-120058708-A Alkynyl alcohol derivative and medical application thereof 中国药科大学 2025-05-30 CN disclosed
US-12252723-B2 Ketoreductase polypeptides and polynucleotides CODEXIS, INC. (US) 2025-03-18 US disclosed
CN-119613408-A Bicyclic ketone compounds and methods of use thereof 豪夫迈·罗氏有限公司 2025-03-14 CN disclosed
CN-110914271-B Bicyclic ketone compounds and methods of use thereof 豪夫迈·罗氏有限公司 2024-12-10 CN disclosed
EP-4467199-A2 SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE JANSSEN Pharmaceutica NV (BE) 2024-11-27 EP disclosed
CN-118908957-A Small molecule inhibitors of NF- κB induced kinase 詹森药业有限公司 2024-11-08 CN disclosed
US-20240335443-A1 IMIDAZOLOPYRIDAZINE OR PYRAZOLOPYRIMIDINE COMPOUNDS AND COMPOSITIONS ANRUI BIOMEDICAL TECHNOLOGY (GUANGZHOU) CO., LTD. (CN) 2024-10-10 US disclosed
WO-2012123522-A1 6,5-HETEROCYCLIC PROPARGYLIC ALCOHOL COMPOUNDS AND USES THEREFOR F. HOFFMANN-LA ROCHE AG (CH) 2012-09-20 WO disclosed
US-20120214762-A1 6,5-HETEROCYCLIC PROPARGYLIC ALCOHOL COMPOUNDS AND USES THEREFOR GENENTECH, INC. (US) 2012-08-23 US disclosed
US-20120214762-A1 6,5-HETEROCYCLIC PROPARGYLIC ALCOHOL COMPOUNDS AND USES THEREFOR GENENTECH, INC. (US) 2012-08-23 US disclosed
US-20120214762-A1 6,5-HETEROCYCLIC PROPARGYLIC ALCOHOL COMPOUNDS AND USES THEREFOR GENENTECH, INC. (US) 2012-08-23 US disclosed
EP-0563286-A4 NOVEL CSAIDS SMITHKLINE BEECHAM CORP (US) 1995-01-11 EP disclosed
EP-0565582-A4 NOVEL CSAIDS. SMITHKLINE BEECHAM CORP (US) 1995-01-11 EP disclosed
EP-0565582-A1 NOVEL CSAIDS SMITHKLINE BEECHAM CORPORATION (US) 1993-10-20 EP disclosed
EP-0563286-A1 NOVEL CSAIDS SMITHKLINE BEECHAM CORPORATION (US) 1993-10-06 EP disclosed
WO-1992010190-A1 NOVEL CSAIDS SMITHKLINE BEECHAM CORPORATION (US) 1992-06-25 WO disclosed
WO-1992010498-A1 NOVEL CSAIDS SMITHKLINE BEECHAM CORPORATION (US) 1992-06-25 WO disclosed